HF progression is associated with pro-inflammatory biomarkers, such as tumor necrosis factor, interleukin-1 (IL-1), interleukin-6 (IL-6), and galectin-3 (Gal-3) [2]. This evidence concerns the gene IL6 and hydrops fetalis.